Related Experiment Video
Updated: Jul 16, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Inpatient Resource Utilization for Hypoplastic Left Heart Syndrome from Birth Through Fontan
Michael Kuntz1, Eleonore Valencia2, Steven Staffa3
1Division of Pediatric Cardiac Anesthesia, Department of Anesthesiology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN, USA.
Insights
The total cost for 3-stage palliation of hypoplastic left heart syndrome (HLHS) is substantial, exceeding $1.4 million. Resource utilization, including hospital days and interstage procedures, has increased in recent years.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Surgery
- Health Economics
Background:
- Hypoplastic left heart syndrome (HLHS) necessitates complex, multi-stage surgical palliation.
- Previous analyses of resource utilization for HLHS palliation are limited.
- Understanding current costs and resource demands is crucial for healthcare planning.
Purpose of the Study:
- To determine the total financial charges associated with completing 3-stage palliation for HLHS.
- To evaluate resource utilization, including hospitalizations and procedures, during the interstage period.
- To identify trends in costs and resource use since prior studies.
Main Methods:
- Retrospective cohort study utilizing the Pediatric Health Information System database (2016-2021).
- Inclusion criteria: patients completing 3-stage palliation for HLHS.
- Analysis of total charges, hospital length of stay, interstage admissions, and procedures.
Main Results:
- Median total adjusted charges for 3-stage palliation were $1,475,800.
- Median hospital lengths of stay were 36 days (Stage 1), 9 days (Stage 2), and 10 days (Stage 3).
- Pulmonary artery stenosis was the most common interstage admission diagnosis; cardiac catheterization and feeding tube placement were frequent procedures.
Conclusions:
- Total inpatient charges for 3-stage HLHS palliation are substantial and appear to have increased.
- Gastrointestinal comorbidities and feeding optimization significantly impact resource utilization.
- Further research into cost-effective management strategies for HLHS is warranted.
Abstract:
Completing 3-stage palliation for hypoplastic left heart syndrome requires significant resources. An analysis of recent data has not been performed. We aimed to determine total charges necessary to complete all 3 stages of single-ventricle palliation, including interstage encounters. We also aimed to determine overall resource utilization, including hospital days, interstage admissions, and interstage procedures. We performed a retrospective cohort study using data from the Pediatric Health Information System database between 2016 and 2021, including all patients who completed 3-stage palliation for hypoplastic left heart syndrome. We identified 199 patients who underwent 3-stage palliation of hypoplastic left heart syndrome between 2016 and 2021. Median total adjusted charges (interquartile range, IQR) over the course of 3-stage palliation were $1,475,800 ($1,028,900-2,191,700). Median adjusted charges (IQR) for stage 1, 2, and 3 hospitalizations were $604,300 ($419,000-891,400), $234,000 ($164,300-370,800), and $256,260 ($178,300-345,900), respectively. Median hospital length of stay (IQR) for stages 1, 2, and 3 was 36 (26,53), 9 (6,17), and 10 (7,14) days, respectively. Pulmonary artery stenosis was the most common admitting diagnosis for interstage hospitalizations (3.4% of hospitalizations). Cardiac catheterization (24.1% of procedures) and feeding tube placement (10.0% of procedures) were the most common principal procedures during interstage hospitalizations. Total inpatient charges incurred throughout 3-stage palliation of hypoplastic left heart syndrome are substantial and have risen since prior studies. Gastrointestinal comorbidities and feeding optimization contribute considerably to this resource utilization.
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Mitral Regurgitation IV: Nursing Management
Mitral Stenosis IV: Nursing Management
Aortic Regurgitation IV: Nursing Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care

